Literature DB >> 27207657

Understanding mutagenesis through delineation of mutational signatures in human cancer.

Mia Petljak, Ludmil B Alexandrov1.   

Abstract

Each individual cell within a human body acquires a certain number of somatic mutations during a course of its lifetime. These mutations originate from a wide spectra of both endogenous and exogenous mutational processes that leave distinct patterns of mutations, termed mutational signatures, embedded within the genomes of all cells. In recent years, the vast amount of data produced by sequencing of cancer genomes was coupled with novel mathematical models and computational tools to generate the first comprehensive map of mutational signatures in human cancer. Up to date, >30 distinct mutational signatures have been identified, and etiologies have been proposed for many of them. This review provides a brief historical background on examination of mutational patterns in human cancer, summarizes the knowledge accumulated since introducing the concept of mutational signatures and discusses their future potential applications and perspectives within the field. Published by Oxford University Press 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27207657     DOI: 10.1093/carcin/bgw055

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  37 in total

1.  DNA polymerase η mutational signatures are found in a variety of different types of cancer.

Authors:  Igor B Rogozin; Alexander Goncearenco; Artem G Lada; Subhajyoti De; Vyacheslav Yurchenko; German Nudelman; Anna R Panchenko; David N Cooper; Youri I Pavlov
Journal:  Cell Cycle       Date:  2018-02-15       Impact factor: 4.534

2.  Modeling cancer rearrangement landscapes.

Authors:  John Maciejowski; Marcin Imielinski
Journal:  Curr Opin Syst Biol       Date:  2016-12-14

Review 3.  The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.

Authors:  Abby M Green; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2019-09-13

4.  Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.

Authors:  Mia Petljak; Ludmil B Alexandrov; Jonathan S Brammeld; Stacey Price; David C Wedge; Sebastian Grossmann; Kevin J Dawson; Young Seok Ju; Francesco Iorio; Jose M C Tubio; Ching Chiek Koh; Ilias Georgakopoulos-Soares; Bernardo Rodríguez-Martín; Burçak Otlu; Sarah O'Meara; Adam P Butler; Andrew Menzies; Shriram G Bhosle; Keiran Raine; David R Jones; Jon W Teague; Kathryn Beal; Calli Latimer; Laura O'Neill; Jorge Zamora; Elizabeth Anderson; Nikita Patel; Mark Maddison; Bee Ling Ng; Jennifer Graham; Mathew J Garnett; Ultan McDermott; Serena Nik-Zainal; Peter J Campbell; Michael R Stratton
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

5.  The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network.

Authors:  Yujing J Heng; Susan E Hankinson; Jun Wang; Ludmil B Alexandrov; Christine B Ambrosone; Victor P de Andrade; Adam M Brufsky; Fergus J Couch; Tari A King; Francesmary Modugno; Celine M Vachon; A Heather Eliassen; Rulla M Tamimi; Peter Kraft
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-01-13       Impact factor: 4.254

Review 6.  Informatics for cancer immunotherapy.

Authors:  J Hammerbacher; A Snyder
Journal:  Ann Oncol       Date:  2017-12-01       Impact factor: 32.976

7.  Exploring background mutational processes to decipher cancer genetic heterogeneity.

Authors:  Alexander Goncearenco; Stephanie L Rager; Minghui Li; Qing-Xiang Sang; Igor B Rogozin; Anna R Panchenko
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

Review 8.  Tumour predisposition and cancer syndromes as models to study gene-environment interactions.

Authors:  Michele Carbone; Sarah T Arron; Bruce Beutler; Angela Bononi; Webster Cavenee; James E Cleaver; Carlo M Croce; Alan D'Andrea; William D Foulkes; Giovanni Gaudino; Joanna L Groden; Elizabeth P Henske; Ian D Hickson; Paul M Hwang; Richard D Kolodner; Tak W Mak; David Malkin; Raymond J Monnat; Flavia Novelli; Harvey I Pass; John H Petrini; Laura S Schmidt; Haining Yang
Journal:  Nat Rev Cancer       Date:  2020-05-29       Impact factor: 60.716

9.  Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting.

Authors:  Peter T Campbell; Christine B Ambrosone; Timothy R Rebbeck; Shuji Ogino; Reiko Nishihara; Hugo J W L Aerts; Melissa Bondy; Nilanjan Chatterjee; Montserrat Garcia-Closas; Marios Giannakis; Jeffrey A Golden; Yujing J Heng; N Sertac Kip; Jill Koshiol; X Shirley Liu; Camila M Lopes-Ramos; Lorelei A Mucci; Jonathan A Nowak; Amanda I Phipps; John Quackenbush; Robert E Schoen; Lynette M Sholl; Rulla M Tamimi; Molin Wang; Matty P Weijenberg; Catherine J Wu; Kana Wu; Song Yao; Kun-Hsing Yu; Xuehong Zhang
Journal:  Cancer Causes Control       Date:  2019-05-08       Impact factor: 2.506

Review 10.  Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution.

Authors:  Subramanian Venkatesan; Charles Swanton; Barry S Taylor; Joseph F Costello
Journal:  Cold Spring Harb Perspect Med       Date:  2017-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.